Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Lucille Packard Children's Hospital Stanford, Palo Alto, California Children's Hospital Colorado, Aurora, Colorado Children's National Medical Center, Washington D.C., District of Columbia Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, Georgia Children's Hospital and Clinics of Minn, Minneapolis, Minnesota St. Jude Children's Research Hospital, Memphis, Tennessee Texas Children's Hospital/ Baylor College of Medicine, Houston, Texas Canada
The Hospital for Sick Children, Toronto, Ontario CHU Sainte-Justine, Montreal BC Children's Hospital Research Institute, Vancouver